Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review
- PMID: 31639495
- PMCID: PMC8928482
- DOI: 10.1016/j.jpainsymman.2019.10.009
Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review
Abstract
Context: There has been surprisingly little attention to conceptual and methodological issues that influence the measurement of discretionary utilization at the end of life (DIAL), an indicator of quality care.
Objective: The objectives of this study were to examine how DIALs have been operationally defined and identify areas where evidence is biased or inadequate to inform practice.
Methods: We conducted a scoping review of the English language literature published from 1/1/04 to 6/30/17. Articles were eligible if they reported data on ≥2 DIALs within 100 days of the deaths of adults aged ≥18 years. We explored the influence of research design on how researchers measure DIALs and whether they examine demographic correlates of DIALs. Other potential biases and influences were explored.
Results: We extracted data from 254 articles published in 79 journals covering research conducted in 29 countries, mostly focused on cancer care (69.1%). More than 100 DIALs have been examined. Relatively crude, simple variables (e.g., intensive care unit admissions [56.9% of studies], chemotherapy [50.8%], palliative care [40.0%]) have been studied more frequently than complex variables (e.g., burdensome transitions; 7.3%). We found considerable variation in the assessment of DIALs, illustrating the role of research design, professional norms and disciplinary habit. Variables are typically chosen with little input from the public (including patients or caregivers) and clinicians. Fewer than half of the studies examined age (44.6%), gender (37.3%), race (26.5%), or socioeconomic (18.5%) correlates of DIALs.
Conclusion: Unwarranted variation in DIAL assessments raises difficult questions concerning how DIALs are defined, by whom, and why. We recommend several strategies for improving DIAL assessments. Improved metrics could be used by the public, patients, caregivers, clinicians, researchers, hospitals, health systems, payers, governments, and others to evaluate and improve end-of-life care.
Keywords: Aggressive care; ICU; aging; biomedical ethics; dying; end-of-life care; health care quality; hospice; life-prolonging; palliative care.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Figures



References
ALPHABETICAL LIST OF INCLUDED STUDIES
-
- Abarshi E, Echteld M, Van den Block L, Donker G, Deliens L, Onwuteaka-Philipsen B. Transitions between care settings at the end of life in the netherlands: Results from a nationwide study. Palliat Med. 2010;24(2):166–174. - PubMed
-
- Abarshi E, Echteld MA, Van den Block L, Donker G, Bossuyt N, Meeussen K, . . . Deliens L. (2011). Use of palliative care services and general practitioner visits at the end of life in the netherlands and belgium. Journal of Pain and Symptom Management, 41(2), 436–448. doi:10.1016/j.jpainsymman.2010.04.016 - DOI - PubMed
-
- Abdollah F, Sammon JD, Majumder K, Reznor G, Gandaglia G, Sood A, . . . Trinh QD (2015). Racial disparities in end-of-life care among patients with prostate cancer: A population-based study. J.Natl.Compr.Canc Netw, 13(9), 1131–1138. - PubMed
References
-
- Brownlee S. Overtreated: Why too much medicine is making us sicker and poorer. New York: Bloomsbury; 2007.
-
- Illich I. Medical nemesis. Bantam Books; New York; 1976.
-
- Le Fanu J. The rise and fall of modern medicine. 2nd ed. New York: Basic Books; 2012.
-
- Rosenthal E. An American sickness: How healthcare became big business and how you can take it back. New York: Penguin; 2017.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources